PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Macrophage-driven immune dysregulation has been shown to be involved in pathophysiology of
diabetic gastroparesis. Currently, there are no non-invasive ways to study macrophage
activation in humans. This study aims to determine the utility of 11C-ER176 based PET-CT
scanning to determine pro-inflammatory macrophage activation in gastric wall of patients with
diabetic gastroparesis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)